Xiaogang Zhao

2.2k total citations
102 papers, 1.6k citations indexed

About

Xiaogang Zhao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaogang Zhao has authored 102 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 32 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Xiaogang Zhao's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastric Cancer Management and Outcomes (7 papers). Xiaogang Zhao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastric Cancer Management and Outcomes (7 papers). Xiaogang Zhao collaborates with scholars based in China, United States and Canada. Xiaogang Zhao's co-authors include Chuanliang Peng, Guimei Lin, Weiquan Zhang, Junwen Luo, Xiaopeng Dong, Qifeng Sun, Licun Wu, Yanbin Shi, Yi Huang and Xianglei Fu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaogang Zhao

92 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaogang Zhao China 22 623 381 318 246 209 102 1.6k
Bin Shi China 22 690 1.1× 469 1.2× 376 1.2× 237 1.0× 238 1.1× 120 2.3k
Badrul Hisham Yahaya Malaysia 21 581 0.9× 274 0.7× 293 0.9× 206 0.8× 250 1.2× 82 1.5k
Yao Lv China 23 667 1.1× 170 0.4× 251 0.8× 216 0.9× 407 1.9× 101 1.8k
Bo Jia China 28 991 1.6× 281 0.7× 283 0.9× 332 1.3× 546 2.6× 135 2.3k
Yingying Hu China 23 666 1.1× 294 0.8× 115 0.4× 228 0.9× 264 1.3× 84 1.8k
Jianhui Li China 28 595 1.0× 192 0.5× 260 0.8× 220 0.9× 335 1.6× 143 2.2k
Yao Xiao China 28 1.1k 1.8× 271 0.7× 258 0.8× 278 1.1× 521 2.5× 102 2.2k
Taiyoun Rhim South Korea 29 742 1.2× 450 1.2× 139 0.4× 225 0.9× 190 0.9× 68 2.1k
Antonio Zizzi Italy 26 572 0.9× 188 0.5× 276 0.9× 188 0.8× 176 0.8× 83 1.8k
Kaijuan Wang China 24 862 1.4× 234 0.6× 249 0.8× 240 1.0× 498 2.4× 105 2.0k

Countries citing papers authored by Xiaogang Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaogang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Zhao more than expected).

Fields of papers citing papers by Xiaogang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaogang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Zhao. The network helps show where Xiaogang Zhao may publish in the future.

Co-authorship network of co-authors of Xiaogang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Zhao. A scholar is included among the top collaborators of Xiaogang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Zhao. Xiaogang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xiaogang, et al.. (2025). Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules. Clinics. 80. 100599–100599.
2.
Wang, Biao, Yi Ding, Zhaohua Xiao, et al.. (2025). Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression. Virulence. 16(1). 2548626–2548626.
3.
Zhao, Yunpeng, Lei Liu, Fengyuan Gao, et al.. (2024). USP21-mediated G3BP1 stabilization accelerates proliferation and metastasis of esophageal squamous cell carcinoma via activating Wnt/β-Catenin signaling. Oncogenesis. 13(1). 23–23. 6 indexed citations
4.
Fan, Guoliang, Jiaxu Wang, Yunfeng Jiang, et al.. (2024). Disulfiram impairs USP21-mediated MOF-K257 deubiquitination to inhibit esophageal squamous cell carcinoma progression. Cancer Letters. 611. 217419–217419. 1 indexed citations
5.
Park, Sun Young, Fengyuan Gao, Lingbing Li, et al.. (2024). Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling. Oncogene. 43(12). 899–917. 12 indexed citations
6.
Liu, Lei, Jinfu Wang, Fengyuan Gao, et al.. (2024). Chronic exposure to hexavalent chromium induces esophageal tumorigenesis via activating the Notch signaling pathway. Journal of Zhejiang University SCIENCE B. 26(1). 76–91.
7.
8.
Xiao, Zhaohua, Xumei Feng, Peiwei Li, et al.. (2023). Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma. International Journal of Nanomedicine. Volume 18. 95–114. 30 indexed citations
9.
Xue, Xia, Junwen Luo, Peiwei Li, et al.. (2023). Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA. Cancer Science. 114(9). 3608–3622. 18 indexed citations
10.
Dai, Jiangnan, Shuai Wang, Pan Chen, et al.. (2023). Fabrication of ultrafiltration membranes with improved antifouling and antibacterial capability by surface modification of quaternary ammonium. European Polymer Journal. 193. 112083–112083. 19 indexed citations
11.
Ni, Ye, Jie Cai, Zhiyuan Bo, et al.. (2022). A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery. Frontiers in Genetics. 13. 928328–928328. 15 indexed citations
12.
Wang, Chuanxin, Yuliang Li, Fujun Zhang, et al.. (2020). Chinese expert consensus workshop report: Guideline for permanent iodine-125 seeds implantation of primary and metastatic lung tumors (2020 edition). Journal of Cancer Research and Therapeutics. 16(7). 1549–1549. 6 indexed citations
13.
Fu, Xianglei, Yanbin Shi, Hui Wang, et al.. (2019). <p>Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4</p>. International Journal of Nanomedicine. Volume 14. 9275–9284. 48 indexed citations
14.
Peng, Chuanliang, et al.. (2014). Effect of Smac and Taxol on non-small-cell lung cancer. Acta Biochimica et Biophysica Sinica. 46(5). 387–393. 7 indexed citations
15.
Dong, Xiaopeng, et al.. (2013). Endostar Combined with Cisplatin Inhibits Tumor Growth and Lymphatic Metastasis of Lewis Lung Carcinoma Xenografts in Mice. Asian Pacific Journal of Cancer Prevention. 14(5). 3079–3083. 17 indexed citations
16.
Peng, Chuanliang, et al.. (2013). Inhibitory Effects of Syk Transfection on Lung Cancer Cell Invasion. Asian Pacific Journal of Cancer Prevention. 14(5). 3001–3003. 8 indexed citations
17.
Peng, Chuanliang, et al.. (2011). Heparanase antisense suppression of A-549 lung carcinoma invasion.. PubMed. 12(12). 3371–4. 2 indexed citations
18.
Peng, Chuanliang, et al.. (2011). VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line.. PubMed. 12(8). 2097–9. 3 indexed citations
19.
Zhao, Xiaogang. (2006). Postoperative Pneumonia due to Cervical Part and Upper Thoracic Part Esophageal Carcinoma Surgery:Retrospective Analysis. Zhongguo yiyuan ganranxue zazhi. 1 indexed citations
20.
Zhao, Xiaogang. (2005). The application of pulsatile catheter pump support on cardiac resuscitation in sheep. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Shi Breakdown of academic impact, for papers by Badrul Hisham Yahaya Breakdown of academic impact, for papers by Yao Lv Breakdown of academic impact, for papers by Bo Jia Breakdown of academic impact, for papers by Yingying Hu Breakdown of academic impact, for papers by Jianhui Li Breakdown of academic impact, for papers by Yao Xiao Breakdown of academic impact, for papers by Taiyoun Rhim Breakdown of academic impact, for papers by Antonio Zizzi Breakdown of academic impact, for papers by Kaijuan Wang
Rankless by CCL
2026